These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12133683)

  • 1. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
    Meier JJ; Gallwitz B; Schmidt WE; Nauck MA
    Lancet; 2002 Jul; 360(9328):257. PubMed ID: 12133683
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
    Landolfi R; De Cristofaro R
    Lancet; 2002 Jul; 360(9328):257. PubMed ID: 12133682
    [No Abstract]   [Full Text] [Related]  

  • 3. Beyond aspirin: how glycoprotein inhibitors ease acute coronary syndromes.
    MacCallum EM; Hanlon SJ; Byrne KH
    Dimens Crit Care Nurs; 2000; 19(3):14-9. PubMed ID: 11998001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controversies surrounding platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention and acute coronary syndromes.
    Harrington RA
    Semin Thromb Hemost; 2004 Dec; 30(6):639-47. PubMed ID: 15630670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet glycoprotein IIb/IIIa inhibitor therapy in non-ST segment elevation acute coronary syndromes.
    Elmouchi DA; Bates ER
    Minerva Cardioangiol; 2003 Oct; 51(5):547-60. PubMed ID: 14551523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Safety and economic efficiency of platelet IIb/IIIa receptor blockers in acute coronary syndromes without ST-segment elevation].
    Latour-Pérez J
    Rev Esp Cardiol; 2000 Aug; 53(8):1148-50. PubMed ID: 11032540
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials.
    Boersma E; Harrington RA; Moliterno DJ; White H; Théroux P; Van de Werf F; de Torbal A; Armstrong PW; Wallentin LC; Wilcox RG; Simes J; Califf RM; Topol EJ; Simoons ML
    Lancet; 2002 Jan; 359(9302):189-98. PubMed ID: 11812552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Abciximab (ReoPro) in the treatment of acute coronary syndromes].
    Rasmussen LH; Husted SE; Kassis E; Kastrup J; Kristensen SD; Pedersen KE; Grande P
    Ugeskr Laeger; 2001 Jan; 163(4):472-7. PubMed ID: 11218792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
    Quinn MJ; Moliterno DJ
    Minerva Cardioangiol; 2002 Oct; 50(5):547-53. PubMed ID: 12384636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute coronary syndrome: are intervention and IIb/IIIa platelet inhibitors epiphenomena?
    Jackson G
    Int J Clin Pract; 2001; 55(6):351-2. PubMed ID: 11501219
    [No Abstract]   [Full Text] [Related]  

  • 11. Glycoprotein IIb/IIIa antagonists in acute coronary syndromes.
    Maree A; Fitzgerald D
    Haematologica; 2001 Nov; 86(11 Suppl 2):45-8. PubMed ID: 11926777
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical trials with glycoprotein IIb/IIIa receptor antagonists in acute coronary syndromes.
    Van de Werf F
    Thromb Haemost; 1997 Jul; 78(1):210-3. PubMed ID: 9198155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of platelet glycoprotein IIb/IIIa receptor inhibitors in acute coronary syndrome and coronary intervention].
    Kakuta T; Kishi Y; Numano F
    Nihon Rinsho; 1998 Oct; 56(10):2630-4. PubMed ID: 9796330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators.
    Lincoff AM; Califf RM; Moliterno DJ; Ellis SG; Ducas J; Kramer JH; Kleiman NS; Cohen EA; Booth JE; Sapp SK; Cabot CF; Topol EJ
    N Engl J Med; 1999 Jul; 341(5):319-27. PubMed ID: 10423466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and safety of glycoprotein IIb/IIIa inhibitors and clopidogrel alone and in combination in non-ST-segment elevation myocardial infarction (from the National Registry of Myocardial Infarction-4).
    Bromberg-Marin G; Marin-Neto JA; Parsons LS; Canto JG; Rogers WJ;
    Am J Cardiol; 2006 Nov; 98(9):1125-31. PubMed ID: 17056312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Glycoprotein IIB/IIIA receptor blockers as treatment of acute coronary syndromes and interventional cardiology].
    Abramovitch N; Halon DA; Flugelman Y; Lewis BS
    Harefuah; 1998 Jul; 135(1-2):41-7. PubMed ID: 10909532
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical studies on glycoprotein IIb/IIIa receptor antagonist].
    Rasmussen LH; Husted SE; Clemmensen PM; Gøtzsche CO; Helqvist S; Kristensen SD; Pedersen KE; Rasmussen K; Rasmussen S
    Ugeskr Laeger; 2000 Oct; 162(44):5944-7. PubMed ID: 11094564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycoprotein IIb/IIIa inhibitors and acute coronary syndromes: summary report of the full submission to NICE, and beyond.
    Manoharan G; Adgey AA
    Heart; 2001 Sep; 86(3):259-61. PubMed ID: 11514474
    [No Abstract]   [Full Text] [Related]  

  • 19. [Inhibitors of platelet receptors GP IIB/IIIA: a new therapeutic class and its promise in the treatment of acute coronary syndromes].
    Yerna M; Legrand V; Kulbertus H
    Rev Med Liege; 1997 May; 52(5):329-35. PubMed ID: 9273634
    [No Abstract]   [Full Text] [Related]  

  • 20. Glycoprotein IIb/IIIa inhibitors.
    Herbert ME; Brewster GS
    Ann Emerg Med; 1999 Sep; 34(3):407-10. PubMed ID: 10459103
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.